AF
ZBIO icon

Allworth Financial’s Zenas BioPharma ZBIO Stock Holding History

Allworth Financial’s Portfolio ZBIO Stock Details ZBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26 Sell
1
-25
-96% -$497 ﹤0.01% 5093
2026
Q1 		$509 Sell
26
-21
-45% -$471 ﹤0.01% 4728
2025
Q4 		$1.71K Buy
+47
New +$1.55K ﹤0.01% 4185

Other funds holding ZBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
RPSM
Royalty Pharma Sub-Manager New York $242M AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

Allworth Financial's ZBIO Position: Q2 2026 in Review

Allworth Financial reduced its Zenas BioPharma (ZBIO) stake by 96% in Q2 2026, selling an estimated $497 and leaving 1 share worth $26. The position accounts for ﹤0.01% of the portfolio, ranked #5093.

Allworth Financial first reported a position in ZBIO in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.71K in Q4 2025. 144 funds tracked by Wall St. Rank hold ZBIO as of Q2 2026.

  • Allworth Financial held 1 share of Zenas BioPharma worth $26 as of Q2 2026.
  • Allworth Financial sold 25 Zenas BioPharma shares in Q2 2026, an estimated $497.
  • Zenas BioPharma made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #5093 holding.
  • Allworth Financial first reported a position in Zenas BioPharma in Q4 2025 and has held it in 3 quarters since.
  • Allworth Financial's Zenas BioPharma position peaked at $1.71K in Q4 2025.
  • 144 funds tracked by Wall St. Rank held Zenas BioPharma as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.